MacroGenics Inc (NASDAQ:MGNX)
| 6.68 Delayed Data As of Mar 24 |  -0.275 / -3.96%Today’s Change | 2.13 Today|||52-Week Range 10.20 | -0.52% Year-to-Date |
Latest MGNX News | Press Releases
| Why MacroGenics Stock Inched Higher on Monday Mar 20 / MotleyFool.com - Paid Partner Content | MacroGenics (MGNX) Q4 2022 Earnings Call Transcript Mar 15 / MotleyFool.com - Paid Partner Content |
| Why MacroGenics Stock Tumbled Today Mar 17 / MotleyFool.com - Paid Partner Content | MacroGenics (MGNX) Surpasses Q4 Earnings Estimates Mar 15 / Zacks.com - Paid Partner Content |
| Why Shares of MacroGenics Climbed Thursday Mar 16 / MotleyFool.com - Paid Partner Content | Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi Mar 14 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.95 |
| Today’s open | 6.95 |
| Day’s range | 6.65 - 6.95 |
| Volume | 11,916 |
| Average volume (3 months) | 776,910 |
| Market cap | $429.2M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +42.18% |
| Earnings growth (this year) | +36.92% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +96.19% |
| P/E ratio | NM |
| Price/Sales | 2.71 |
| Price/Book | 3.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARCTArcturus Therapeutic... | +0.63 | +4.17% |
| --Tempo Scan Pacific T... | 0.00 | 0.00% |
| AMRXAmneal Pharmaceutica... | +0.03 | +2.29% |
| ---- |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | $0.58 |
| Annual revenue (last year) | $151.9M |
| Annual profit (last year) | -$119.8M |
| Net profit margin | -78.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
